Literature DB >> 24282359

Dendritic cell co-stimulatory and co-inhibitory markers in chronic HCV: an Egyptian study.

Hanan Fouad1, Maissa Saeed El Raziky, Rasha Ahmed Abdel Aziz, Dina Sabry, Ghada Mahmoud Abdel Aziz, Manal Ewais, Ahmed Reda Sayed.   

Abstract

AIM: To assess co-stimulatory and co-inhibitory markers of dendritic cells (DCs) in hepatitis C virus (HCV) infected subjects with and without uremia.
METHODS: Three subject groups were included in the study: group 1 involved 50 control subjects, group 2 involved 50 patients with chronic HCV infection and group 3 involved 50 HCV uremic subjects undergoing hemodialysis. CD83, CD86 and CD40 as co-stimulatory markers and PD-L1 as a co-inhibitory marker were assessed in peripheral blood mononuclear cells by real-time polymerase chain reaction. Interleukin-10 (IL-10) and hyaluronic acid (HA) levels were also assessed. All findings were correlated with disease activity, viral load and fibrogenesis.
RESULTS: There was a significant decrease in co-stimulatory markers; CD83, CD86 and CD40 in groups 2 and 3 vs the control group. Co-stimulatory markers were significantly higher in group 3 vs group 2. There was a significant elevation in PD-L1 in both HCV groups vs the control group. PD-L1 was significantly lower in group 3 vs group 2. There was a significant elevation in IL-10 and HA levels in groups 2 and 3, where IL-10 was higher in group 3 and HA was lower in group 3 vs group 2. HA level was significantly correlated with disease activity and fibrosis grade in group 2. IL-10 was significantly correlated with fibrosis grade in group 2. There were significant negative correlations between co-stimulatory markers and viral load in groups 2 and 3, except CD83 in dialysis patients. There was a significant positive correlation between PD-L1 and viral load in both HCV groups.
CONCLUSION: A significant decrease in DC co-stimulatory markers and a significant increase in a DC co-inhibitory marker were observed in HCV subjects and to a lesser extent in dialysis patients.

Entities:  

Keywords:  CD83; CD86, CD40; Dendritic cells; Hemodialysis; Hepatitis C virus; Hyaluronic acid; Interleukin-10; PD-L1; Uremia

Mesh:

Substances:

Year:  2013        PMID: 24282359      PMCID: PMC3837270          DOI: 10.3748/wjg.v19.i43.7711

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  39 in total

Review 1.  Altered innate immunity in chronic hepatitis C infection: cause or effect?

Authors:  Gyongyi Szabo; Serena Chang; Angela Dolganiuc
Journal:  Hepatology       Date:  2007-10       Impact factor: 17.425

Review 2.  Innate sensing of self and non-self RNAs by Toll-like receptors.

Authors:  Mouldy Sioud
Journal:  Trends Mol Med       Date:  2006-03-10       Impact factor: 11.951

3.  Interaction between the HCV NS3 protein and the host TBK1 protein leads to inhibition of cellular antiviral responses.

Authors:  Motoyuki Otsuka; Naoya Kato; Masaru Moriyama; Hiroyoshi Taniguchi; Yue Wang; Narayan Dharel; Takao Kawabe; Masao Omata
Journal:  Hepatology       Date:  2005-05       Impact factor: 17.425

4.  Impaired function of dendritic cells circulating in patients infected with hepatitis C virus who have persistently normal alanine aminotransferase levels.

Authors:  Tatsuya Kanto; Michiyo Inoue; Masanori Miyazaki; Ichiyo Itose; Hideki Miyatake; Mitsuru Sakakibara; Takayuki Yakushijin; Aki Kaimori; Chika Oki; Naoki Hiramatsu; Akinori Kasahara; Norio Hayashi
Journal:  Intervirology       Date:  2006       Impact factor: 1.763

5.  Functional impairment of monocyte-derived dendritic cells in patients with severe chronic kidney disease.

Authors:  Martijn Anton Verkade; Corné Johan van Druningen; Leonard Maria Bernardus Vaessen; Dennis Adriaan Hesselink; Willem Weimar; Michiel Gerardus Henricus Betjes
Journal:  Nephrol Dial Transplant       Date:  2006-09-27       Impact factor: 5.992

6.  Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection.

Authors:  Angela Dolganiuc; Serena Chang; Karen Kodys; Pranoti Mandrekar; Gennadiy Bakis; Maureen Cormier; Gyongyi Szabo
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

Review 7.  Adaptive immune responses in acute and chronic hepatitis C virus infection.

Authors:  David G Bowen; Christopher M Walker
Journal:  Nature       Date:  2005-08-18       Impact factor: 49.962

Review 8.  Liver biopsy assessment in chronic viral hepatitis: a personal, practical approach.

Authors:  Neil D Theise
Journal:  Mod Pathol       Date:  2007-02       Impact factor: 7.842

9.  Monocyte-derived dendritic cell function in chronic hepatitis C is impaired at physiological numbers of dendritic cells.

Authors:  A J MacDonald; A E Semper; N A Libri; W M C Rosenberg
Journal:  Clin Exp Immunol       Date:  2007-03-15       Impact factor: 4.330

10.  Monocyte derived dendritic cells retain their functional capacity in patients following infection with hepatitis C virus.

Authors:  E Barnes; M Salio; V Cerundolo; L Francesco; D Pardoll; P Klenerman; A Cox
Journal:  J Viral Hepat       Date:  2008-01-10       Impact factor: 3.728

View more
  4 in total

Review 1.  Mononuclear phagocyte system in hepatitis C virus infection.

Authors:  Yu Yang; Zheng-Kun Tu; Xing-Kai Liu; Ping Zhang
Journal:  World J Gastroenterol       Date:  2018-11-28       Impact factor: 5.742

Review 2.  Recent Findings in the Regulation of Programmed Death Ligand 1 Expression.

Authors:  Xiangfeng Shen; Lihong Zhang; Jicheng Li; Yulin Li; Yishu Wang; Zhi-Xiang Xu
Journal:  Front Immunol       Date:  2019-06-14       Impact factor: 7.561

Review 3.  Hyaluronic acid as a biomarker of fibrosis in chronic liver diseases of different etiologies.

Authors:  Olga Hilda Orasan; George Ciulei; Angela Cozma; Madalina Sava; Dan Lucian Dumitrascu
Journal:  Clujul Med       Date:  2016-01-15

Review 4.  Humanized Mice as an Effective Evaluation System for Peptide Vaccines and Immune Checkpoint Inhibitors.

Authors:  Yoshie Kametani; Yusuke Ohno; Shino Ohshima; Banri Tsuda; Atsushi Yasuda; Toshiro Seki; Ryoji Ito; Yutaka Tokuda
Journal:  Int J Mol Sci       Date:  2019-12-16       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.